Press Releases | Press Release - Ultromics
Skip to content
Home
Products
AI-powered HFpEF Detection
AI-powered Cardiac Amyloidosis Detection
Solutions for
Individuals
Providers
Payers
About
About Ultromics
Team
Partners
EchoGo® Integration
Careers
Events
Awards
News
Perspectives Blog
Press Releases
Resources
The Proof
Clinical Research Dossier
Webinars
Reimbursement
Contact
Contact Us
Customer Support
Menu
Press releases
Discover latest product news and media coverage about Ultromics.
Showing posts in the category '
Press Release
'
Show all posts
28th March 2025
Ultromics Introduces AI-Powered Probability Scoring on EchoGo® Heart Failure for Enhanced HFpEF Diagnosis
12th December 2024
CMS Updates Final Outpatient Clinical APC Rule for Ultromics’ EchoGo® Heart Failure
20th November 2024
Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program
30th July 2024
Study Confirms AI-Based Detection of HFpEF is Linked to Cardiac Outcomes
9th July 2024
EchoGo® Featured in Hot Line and Late-Breaking Science Sessions at ESC Congress 2024
2nd July 2024
Ultromics granted CPT III reimbursement code for EchoGo® Heart Failure
9th January 2024
Ultromics announces partnership to expedite development of Echo AI algorithm for earlier detection of cardiac amyloidosis
7th November 2023
CMS publishes final Clinical APC rule for Ultromics EchoGo® Heart Failure
2nd August 2023
New Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF Diagnosis
31st July 2023
Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View
5th July 2023
CMS Establishes HCPCS code for Ultromics EchoGo® Heart Failure, Accelerating Access to Precision HFpEF Detection
26th April 2023
Ultromics granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis detection
Pagination
Go to page
1
Go to page
2
Go to page
3
Go to page
4
Go to
Next
page
Coverage
Can AI give radiology the urgent jump-start it needs?
Startups Seek to Unravel Cardiovascular-Disease Mysteries in Covid-19
How AI could help health providers diagnose COVID-19
Covid-19 has presented the possibility of reinventing healthcare delivery
Ultromics scores $10M for its cardiac decision support tool
Ultromics AI platform to expand trials to 20 NHS hospitals
FDA Clears AI-powered Cardiac Echo Analysis and Quantification by Ultromics
AI transformation in a post-pandemic world
Ultromics on BBC NEWS
Artificial intelligence 'to diagnose heart disease'
The Young BioTech Entrepreneurs Bringing Grey Hair Into The C-Suite
Artificial intelligence will improve medical treatments
